Atjaunināt sīkdatņu piekrišanu

E-grāmata: Drug Safety in Developing Countries: Achievements and Challenges

3.00/5 (2 ratings by Goodreads)
Edited by (Professor of Clinical Pharmacy, College of Pharmacy, University of Science and Technology of Fujairah, Fujairah, United Arab Emirates; Deputy Dean and Professor, College of Medical Sciences, Azal University for Human Development, Sanaa, )
  • Formāts: EPUB+DRM
  • Izdošanas datums: 03-Jun-2020
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780128204122
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 164,36 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Drug Safety in Developing Countries: Achievements and ChallengesPalielināt
  • Formāts: EPUB+DRM
  • Izdošanas datums: 03-Jun-2020
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780128204122
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.

  • Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues
  • Describes current achievements of drug safety practice in developing countries
  • Addresses the challenges of drug safety in developing countries
  • Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Recenzijas

"This book offers a unique perspective on drug safety issues in developing countries and a comparison of different aspects including pharmacovigilance, medication errors, counterfeit medications, abuse, and storage and disposal. It highlights achievements and challenges for drug safety issues in over 21 countries and offers solutions to overcome these barriers. The significance of this book allows readers to understand how these drug safety challenges in developing countries can be improved to reduce adverse drug events to lower morbidity and mortality." --Doody Reviews

Section 1 Drug safety-related issues
1. Introduction: Why do we need a book on drug safety in developing countries?
2. Medications safety-related terminology
3. Medications registration and marketing: safety-related issues
4. Pharmacovigilance
5. Adverse drug reactions
6. Medication errors
7. Self-medication
8. Antibiotics safety issue
9. Drug-related problems
10. Counterfeit and substandard medications
11. Medication abuse and misuse
12. Storage and disposal of medications
13. Safety of medications in special population
14. Herbal medicines safety issues
15. Medications safety resources and tools
16. Medications safety pharmacoeconomics-related issues
17. Evidence-based medications safety practice
18. Technology in medications safety
19. Medications safety research issues
20. Quality indicators for medications safety

Section 2: Drug Safety in Asia 21. Drug safety in Malaysia
22. Drug safety in Thailand
23. Drug safety in Indonesia
24. Drug safety in Pakistan
25. Drug safety in India
26. Drug safety in Nepal
27. Drug safety in Sri Lanka
28. Drug Safety in China

Section 3: Drug Safety in Middle East 29. Drug safety in Yemen
30. Drug safety in Saudi Arabia
31. Drug safety in UAE
32. Drug safety in Jordan
33. Drug safety in Lebanon
34. Drug safety in Palestine
35. Drug safety in Qatar

Section 4: Drug Safety in Africa
36. Drug safety in Sudan
37. Drug safety in Egypt
38. Drug safety in Nigeria
39. Drug safety in Mali
40. Drug safety in Burkina Faso

Section 5: Drug Safety in Latin America 41. Drug safety in Chile

Section 6: Comparisons and conclusions
42. Compare between the developing countries
43. Drug Safety in Developing Versus Developed countries

Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sanaa University, Yemen and obtained a Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 20 years experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & learning committee, Head of Training Committee, head of the curriculum committee and other committees. He has authored over 100 peer-reviewed papers in international journals, and book chapters and edited more than 10 books by Elsevier, Springer, Taylors & Francis, USA. Prof.Yaser has supervised/co-supervised many PhD, Master, PharmD and B-Pharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser prepared, designed, and wrote many pharmacy programs for many universities including Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients care.
Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97801282041226e.html
Keywords: